Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Water Research|June 14, 2024
Understanding visible light and microbe-driven degradation mechanisms of polyurethane plastics: Pathways, property changes, and product analysisHongyu Tian, Yuping Du, Xinyu Luo, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 10, 2024
Manipulating 2D Membrane Interlayer Channels with Accelerated Mass-Transfer Behavior to Boost Solar DesalinationYuping Du, He Zhang, Lie Zou, et al.
Plos One|June 1, 2011
Modeling a new water channel that allows SET9 to dimethylate p53Qifeng Bai, Yulin Shen, Xiaojun Yao, et al.
Wei Sheng Yan Jiu = Journal of Hygiene Research|June 23, 2025
[Nutritional risk investigation and related factors of 197 patients with early-stage non-small cell lung cancer]Jing Ai, Yuping Du, Chonglin Wang, et al.
Oncology Letters|February 10, 2018
Inhibition of breast cancer cell survival by Xanthohumol via modulation of the Notch signaling pathway in vivo and in vitroZhihong Sun, Cheng Zhou, Feng Liu, et al.
Molecular Cancer|March 19, 2025
Lactate accumulation induces H4K12la to activate super-enhancer-driven RAD23A expression and promote niraparib resistance in ovarian cancerBingfeng Lu, Shuo Chen, Xue Guan, et al.
Molecular Cancer Therapeutics|January 10, 2014
TPCA-1 is a direct dual inhibitor of STAT3 and NF-κB and regresses mutant EGFR-associated human non-small cell lung cancersJing Nan, Yuping Du, Xing Chen, et al.
Cancer Letters|August 10, 2014
N6-substituted adenosine analogues, a novel class of JAK2 inhibitors, potently block STAT3 signaling in human cancer cellsPeng Liu, Liwei Zhao, Ximing Xu, et al.
Molecular Pharmacology|January 14, 2015
Dehydrocrenatidine is a novel janus kinase inhibitorJing Zhang, Ning Zhu, Yuping Du, et al.
Investigational New Drugs|October 16, 2019
Discovery and evaluation of Atopaxar hydrobromide, a novel JAK1 and JAK2 inhibitor, selectively induces apoptosis of cancer cells with constitutively activated STAT3Jingjie Sun, Yuping Du, Xinxin Zhang, et al.
Pageof 5